Age-Related Macular Degeneration Is Associated with Less Physical Activity among US Adults: Cross-Sectional Study

Paul D. Loprinzi; Bonnielin K. Swenor; Pradeep Y. Ramulu

doi:10.1371/journal.pone.0125394

Abstract

Background

We have a limited understanding of the effects of age-related macular degeneration (AMD) on physical activity (PA), and we have no prevalence estimates of the daily movement patterns among Americans with AMD. Therefore, we examined the association between AMD and PA and provided estimates of the daily movement patterns of Americans with AMD.

Methods

Data from the 2005-2006 National Health and Nutrition Examination Survey were used, including 1,656 adults (40-85 yrs). Retinal imaging was performed to classify individuals as no AMD, early AMD, or late AMD. Participants wore an ActiGraph 7164 accelerometer for 7 days to measure PA behavior.

Results

93.2% of participants with late AMD were in the least desirable group (not sufficiently active and having a negative light intensity-sedentary behavior balance). After adjustments (including age), participants with late AMD, as compared to those with no AMD, engaged in 50% less moderate-to-vigorous physical activity (MVPA) (RR = 0.50; 95% CI: 0.28-0.90). When visual acuity was entered into the model along with the other covariates, the association between late AMD and MVPA was no longer significant (RR = 0.54; 95% CI: 0.29-1.01), suggesting that visual acuity may partially mediate this relationship.

Conclusions

Individuals with late AMD engage in very little moderate-to-vigorous physical activity. Visually acuity, in part, explains the relationship between late AMD and PA.

Citation: Loprinzi PD, Swenor BK, Ramulu PY (2015) Age-Related Macular Degeneration Is Associated with Less Physical Activity among US Adults: Cross-Sectional Study. PLoS ONE 10(5): e0125394. https://doi.org/10.1371/journal.pone.0125394

Academic Editor: Torben Lykke Sørensen, Copenhagen University Hospital Roskilde and the University of Copenhagen, DENMARK

Received: September 14, 2014; Accepted: March 24, 2015; Published: May 1, 2015

Copyright: © 2015 Loprinzi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Data Availability: All data are publicly accessible and available from the NHANES website: http://www.cdc.gov/nchs/nhanes.htm.

Funding: This work was supported by Research to Prevent Blindness (http://www.rpbusa.org/rpb/) and National Institutes of Health grants EY015025 and EY022976 (PYR; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Age-related macular degeneration (AMD) is the leading cause of vision loss among adults in industrialized countries [1,2], particularly older white Americans [3]. Early AMD occurs with milder stages of the “dry” form of the disease, marked by the presence of drusen and/or pigment epithelial changes. Late AMD occurs with the “wet” form of the disease (marked by choroidal neovascularization in the macula) or with advanced stages of the “dry” form of the disease, marked by geographic atrophy. In both stages of AMD vision is impaired, though to differing degrees. Vision loss associated with AMD may impair quality of life through various ways, including increased morbidity [4,5], difficulty recognizing faces, watching television, reading fine print [6,7], and decreasing functional independence [8,9].

Vision loss associated with AMD may also negatively influence other aspects of an individual’s health, as recent work demonstrates that those with vision impairment engage in less moderate-to-vigorous physical activity (MVPA) than those without vision impairment [10]. This is concerning, as insufficient participation in physical activity may increase the risk of developing metabolic, cardiovascular, and cerebrovascular diseases [11] that are associated with vision loss, systemic illness, and premature mortality [12,13].

Prior research has found that both AMD and impaired visual acuity are associated with reduced physical activity. One study has recently reported lower physical activity levels among those with impaired visual acuity [10]. Similarly, few studies have examined the association between AMD and physical activity. Results from these prior studies are mixed [14–19], with most studies demonstrating that AMD is associated with reduced physical activity levels. These prior studies have two major shortcomings: (a) none examine the association between AMD and physical activity after controlling for visual acuity; therefore, it is uncertain whether AMD or visual acuity is driving the potential relationship between AMD and physical activity; and (b) each of the 6 studies examining the association between AMD and physical activity have exclusively used self-report physical activity methodology. Previous work has shown that self-report physical activity is prone to considerable measurement error [20], and serious concerns have been raised regarding the validity of this method [21]. Validation studies examining the association between self-report physical activity and some gold-standard (e.g., accelerometry, indirect calorimetry, and doubly labeled water) typically show a poor correlation in the range of 0.3–0.5 [22]. Thus, these ‘validated’ self-report questionnaires only account for 9–25% of the variance in the outcome parameter and are therefore likely to result in considerable misclassification.

Here, we investigate the association between physical activity and AMD using an objective-measure of physical activity (accelerometry). Our search of the literature found no studies that have provided estimates of the daily movement patterns of Americans comparing those with and without AMD. Consequently, we have no information about the risk that these individuals may have for developing negative health outcomes associated with physical inactivity. Additionally, it is unknown if the association between AMD and physical activity is due to resulting impaired visual acuity.

This study hypothesizes that: a) the estimates of the daily movement patterns of American adults will be lower in those with AMD (particularly those with advanced AMD) as compared to without AMD; b) adults with AMD engage in less physical activity than those without AMD after accounting for potential confounders of this relationship; and c) this association will be partially explained by visual acuity impairment. To maximize the generalizability of our findings, we study these questions using a nationally representative sample of U.S. adults participating in the National Health and Nutrition Examination Survey (NHANES).

Methods

Design and Participants

NHANES is an ongoing survey conducted by the National Center for Health Statistics which evaluates a representative sample of non-institutionalized U.S. civilians. Participants are selected by a complex, multistage probability design. Data from the 2005–2006 NHANES were used, as this is the only NHANES cycle with both retinal imaging/grading and accelerometry data. All procedures for data collection were approved by the NCHS ethics review board, and all participants provided written informed consent prior to data collection. NHANES is publically accessible data and the authors used NHANES data for secondary analyses (http://www.cdc.gov/nchs/nhanes.htm). Participants were eligible for our analyses if they provided sufficient accelerometry data (≥ 4 days of 10+ hrs/day of monitoring data), had analyzable retinal imaging data, and provided data on the study covariates. In the 2005–2006 NHANES cycle, 2,413 participants were eligible for the retinal exam. After excluding those with insufficient accelerometry data or missing data on the covariates, 1,656 participants remained, which constituted the analytic sample. There were no differences in the study variables between the analytic sample and those excluded. Characteristics of study participants by AMD category are shown in Table 1.

Download:

Table 1. Weighted characteristics of the analyzed sample by age-related macular degeneration (AMD) severity, NHANES 2005–2006.

https://doi.org/10.1371/journal.pone.0125394.t001

Assessment of Age-Related Macular Degeneration

Participants aged 40 years and older were eligible for the retinal imaging exam unless they were unable to see light with both eyes open or had an eye infection. Detailed procedures of the retinal imaging exam performed in the NHANES 2005–2006 cycle can be found elsewhere (http://www.cdc.gov/nchs/nhanes/nhanes2005-2006/OPXRET_D.htm). Briefly, retinal imaging was performed using the Canon Non-Mydratic Retinal Camera CR6-45NM (Canon, Tokyo, Japan). Two forty-five degree digital images were obtained on both eyes and graded using the University of Wisconsin Age-Related Maculopathy Grading System for AMD. Further details can be found elsewhere (http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/NHANES_ophthamology_digital_grading_protocol.pdf). Using the worse eye in reference to AMD severity, early AMD was defined as either soft drusen greater than 500μ and a pigmentary abnormaility, or soft drusen within the center grading circle [diameter = 1 disc diameter; centered on the fovea] and a pigment abnormality. Late AMD was defined by the presence of any late lesions, such as choroidal neovascularization, subretinal fibrous scare, and/or geographic atrophy. Further details can be found elsewhere (http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/NHANES_ophthamology_digital_grading_protocol.pdf).

Assessment of Physical Activity

Participants who were able to walk were asked to wear an ActiGraph 7164 accelerometer on their right hip for 7 days. As distributed by NHANES personnel, accelerometers were affixed to an elastic belt that was worn around the participant’s waist near the iliac crest. Accelerometry provides an objective measure of the intensity, frequency and duration physical activity. Participants were asked to wear the accelerometer during all activities except water-based activities and sleeping. The accelerometer measured the frequency, intensity, and duration of physical activity by generating an activity count proportional to the measured acceleration.

Time spent at different physical activity intensities was assessed over 1-minute intervals, with each minute classified as sedentary, light, moderate, or vigorous. Time spent in either moderate and vigorous activity was defined as moderate-to-vigorous physical activity (MVPA), as participants engaged in very little vigorous-intensity physical activity (mean = 0.71 min/day; SE = 0.07). Using the SAS code provided by the National Center for Health Statistics, an activity count below 100 counts per minute (i.e., 0 to 99) was used to classify sedentary behavior [23]; activity counts between 100 and 2019 counts per minute were used to classify time spent in light-intensity physical activity; activity counts between 2020 and 5998 counts per minute were used to classify time spent at moderate-intensity [24]; and activity counts at or greater than 5999 counts per minute were used to classify time spent at vigorous-intensity [24]. Only those participants with at least 4 days of 10 or more hours/day of accelerometer wear time were included in the analyses in order to make sure that data adequately captured habitual physical activity patterns [24]. To monitor the amount of time the device was worn, nonwear was defined by a period of a minimum of 60 consecutive minutes of zero activity counts, with the allowance of 1–2 minutes of activity counts between 0 and 100 [24]. Each participants average time spent per day in physical activity from valid accelerometry data were analyzed.

Daily Movement Patterns

Using the accelerometry data, participants were defined as sufficiently active if they engaged in at least 150 minutes of moderate-intensity physical activity per week, 75 minutes of vigorous-intensity physical activity per week, or some combination of the two. Four mutually exclusive daily movement patterns were created to account for whether individuals were sufficiently active for weekly MVPA, and also to account for the importance of sedentary behavior and light-intensity physical activity (LPA) [25,26]: a) participants are sufficiently active and having a positive light-intensity physical activity-sedentary (LPA-SED) balance (i.e., LPA ≥ SED); b) participants are sufficiently active, but having a negative LPA-SED balance (i.e., LPA < SED); c) participants not sufficiently active, but having a positive LPA-SED balance; and d) participants not sufficiently active and having a negative LPA-SED balance. Conceptually, the four groups represent a continuum with participants in the first group considered to be the most active/desirable group and participants in the last group being considered the least active/desirable group. This novel daily movement pattern classification takes into consideration the emerging work demonstrating independent effects of sedentary behavior and light-intensity physical activity on health.

Measurement of Covariates

Potential covariates were considered on the basis of previous research demonstrating an association with physical activity and AMD. Covariates considered included: age, gender, race/ethnicity, body mass index (BMI), mean arterial pressure (MAP), cotinine, coronary heart disease, stroke, diabetes, accelerometer wear time, number of valid accelerometer days and visual acuity.

Questionnaires were completed to assess age, gender, race/ethnicity, and comorbid illness. Comorbid illness (coronary heart disease, stroke, diabetes) were defined as present if patients reported that they had been told by a health care professional that they had the condition. Participants were also considered to have diabetes if they were taking insulin or diabetic pills to lower blood sugar, had a HgbA1_C of 6.5% or greater, or had a fasting glucose level of 126 mg/dL or higher. Body mass index was assessed from measured weight and height (kg/m²).

Blood pressure was measured up to 4 times, and the mean arterial pressure ([diastolic blood pressure x 2)+systolic blood pressure]/3) was calculated from the available blood pressure measurements. Serum cotinine was measured by an isotope dilution high performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry.

Details regarding the NHANES vision assessment are described elsewhere [10]. Briefly, presenting visual acuity for each eye was assessed using the ARK-760 (Nidek Co Ltd, Tokyo, Japan), an autorefractor containing built-in visual acuity charts and participants wearing their presenting correction (if any). Visual acuity was also rechecked after auto-refraction in eyes with a presenting visual acuity worse than 20/25. Visual acuity of the better-seeing eye was used given that sight in the better eye is most relevant to disability in numerous visual disorders [27,28]; analyses were also computed with visual acuity as the worse-seeing eye, but results were similar, so visual acuity of the better-seeing eye was used. Presenting visual acuity of the better-eye was treated as a continuous variable expressed in logMAR units (logarithm of the minimum angle of resolution).

With regard to the classification of visual function, participants with presenting visual acuity of 20/40 or better in either eye were classified as having normal sight. Participants with presenting visual acuities worse than 20/40, but postrefraction visual acuity in either eye of 20/40 or better, were classified as having uncorrected refractive error (URE). Participants with visual acuities worse than 20/40 after autorefraction, or who self-reported not being able to see light with both eyes open, were classified as having vision impairment (VI). Participants with missing data for presenting acuity in both eyes, or with visual acuity worse than 20/40 in both eyes with no autorefraction in either eye, were excluded from the analysis as they were considered to have incomplete visual acuity data.

Data Analysis

All statistical analyses were performed using procedures from sample survey data using Stata (version 12.0, College Station, TX) to account for the complex survey design used in NHANES. Mobile Exam Center (MEC) sample weights were used to provide nationally representative estimates. In an effort to maintain nationally representative estimates, the sample weights for those with 4 or more days of valid accelerometry data were ratio-adjusted to maintain the age, sex, and race-ethnicity distribution of the full sample.

The percentage of participants in each AMD category was determined for each of the four daily movement patterns described above. Negative binomial regression models were used to determine the association between AMD and MVPA, as MVPA time is an outcome variable expressed in integral minutes and was positively skewed. Coefficients from negative binomial models are expressed as rate ratios (RR), reflecting the relative rate of events (i.e. MVPA) associated with specific model elements over a specific period of time (i.e. day). Two models were computed, with Model 1 including all covariates with the exception of visual acuity, and Model 2 included these covariates plus visual acuity. This second model was used to determine whether visual acuity attenuated the association between AMD and MVPA. Multivariable linear regression models were used to determine the association between AMD with sedentary behavior and light-intensity physical activity, as sedentary behavior and light-intensity physical activity (outcome variables) were not severely skewed. Similar to the MVPA analyses, visual acuity was added to these models to determine if the association between AMD and sedentary behavior and light-intensity physical activity was attenuated. For all analyses, p < 0.05 was established as statistical significance.

Results

Among the 1,656 participants, 183 had a presenting visual acuity worse than 20/40 (logMAR 0.3) and 15 had a presenting visual acuity of 20/200 or worse (logMAR 1.0) (not shown in tabular format). After autorefraction, and using the procedures reported elsewhere [29], 1,526, 99, and 31 participants, respectively, had normal vision, uncorrected refractive error, and vision impairment. In the sample with no AMD, 99.4% had normal vision or URE, with 0.6% having VI; in those with early AMD, 96.4% had normal vision or URE, with 3.6% having VI; among those with late AMD, 56.4% had normal vision or URE, with 43.6% having VI.

Participants with more severe AMD had worse presenting visual acuity (Table 1). In models also controlling for age, gender, race-ethnicity, BMI, cotinine, MAP, comorbid illness, accelerometer wear time and number of valid accelerometry days, participants with early (β = 0.03; p = 0.01) and late AMD (β = 0.31; p < 0.01) had worse visual acuity than those with no AMD.

As shown in Table 1, participants with no AMD, early AMD, and late AMD, respectively, spent an average of 494, 527, and 573 min/day in sedentary behavior. Participants in these groups also averaged 348, 317, and 252 min/day of light-intensity physical activity respectively. Lastly, MVPA estimates were 21, 14, and 4 min/day respectively. For all estimates, those with late AMD engaged in significantly (p < 0.05) more sedentary behavior and less physical activity (both light-intensity and MVPA) than those with no AMD, with large effect sizes (η² ≥ 0.5) noted for light-intensity physical activity and MVPA. Very few participants with AMD, particularly those with advanced AMD, demonstrated more beneficial physical activity characteristics, as noted from the 4 daily movement pattern groups.

The association between MVPA and AMD was examined in multivariable negative binomial models (Table 2). Unadjusted results were as follows: participants with early and late AMD, respectively, engaged in 34% (RR = 0.66; 95% CI: 0.46–0.95) and 72% (RR = 0.18: 95% CI: 0.09–0.34) less MVPA as compared to those with no AMD. After controlling for age, gender, race-ethnicity, BMI, cotinine, MAP, comorbid illness, accelerometer wear time an number of valid accelerometer days (model 1), participants with late AMD, as compared to those with no AMD, engaged in 50% less MVPA (RR = 0.50; 95% CI: 0.28–0.90). When visual acuity was entered into the model (model 2), the association between MVPA and late AMD was no longer statistically significant, though the magnitude and direction of the association was similar (RR = 0.54; 95% CI: 0.29–1.01), suggesting that visual acuity may be accounting for 8% ([0.50–0.54/0.50]*100) of the total effect between AMD and MVPA. AMD was not significantly associated with sedentary behavior or light-intensity physical activity in the multivariate models (data not shown).

Download:

Table 2. Weighted regression analyses examining the association between moderate-to-vigorous physical activity (outcome variable) and AMD, NHANES 2005–2006.

https://doi.org/10.1371/journal.pone.0125394.t002

Discussion

The aims of this study were to a) descriptively classify the daily movement patterns among U.S. adults with and without AMD and b) examine the association of AMD with physical activity while controlling for visual acuity along with other confounding variables. In a nationally representative sample of U.S. adults, individuals with late AMD spent significantly less time engaging in MVPA than those with early AMD or without AMD. Further, the majority of participants with early or late AMD engaged in the least desirable movement patterns, i.e., were not sufficiently active and engaged in more sedentary behavior than light-intensity physical activity. After including visual acuity to our analytic models, we found that the association between late AMD and MVPA was attenuated and no longer significant. We calculated that visual acuity may be accounting for 8% of the total effect of late AMD on physical activity.

The hypothesized role of visual acuity on the association between AMD and MVPA was based on the association between AMD and impaired visual acuity, as well as prior research indicating that vision loss may reduce physical activity participation. With regard to the latter, and although findings are mixed [14–19], most studies demonstrate an association between AMD and self-reported participation in physical activity, though no study has examined the association between AMD and objectively-measured physical activity. This potential reduction in MVPA may occur through various mechanisms, including decreased balance and fear of falling [30], which ultimately may affect their ability and/or inclination to engage in MVPA. Further, impaired balance associated with reduced visual acuity may specifically be due to worse vestibular balance, postural instability and problems with edge detection and navigation [30]. This is concerning, as insufficient participation in physical activity may increase the risk of developing various cardiovascular disease risk factors and other chronic diseases. Not only does physical inactivity increase the occurrence of various deleterious metabolic and vascular diseases, but, in theory, physical inactivity may be considered prodegenerative and facilitate the progression of vision loss and AMD in some cases [19], i.e., from sedentary behavior-induced increases in inflammation and endothelial dysfunction [31,32], which is supported by recent research [33]. Consequently, it is plausible to suggest a bidirectional relationship between physical activity and AMD [19].

While this is the first study to examine the role of visual acuity on the association between AMD and physical activity, there are potential limitations that should be considered. Although accelerometry is considered the standard of choice for measuring free-living physical activity behavior, accelerometry has notable limitations including an underestimation of physical activity from certain modes of physical activity, such as cycling or swimming. However, this limitation may be less of a concern among adults as their most common type of physical activity is walking [34]. Further, it is possible that other unmeasured factors may be influencing the association between AMD and physical activity which could affect the observed level of attenuation attributed to visual acuity. But, there is no statistical test to definitively determine the presence of unmeasured confounders that may influence this association. We can only make speculations as to what potential unmeasured factors were not collected in NHANES. One such factor may be the duration of vision loss, as this may influence emotional distress. Individuals having a shorter period of perceived vision loss are more likely to report higher levels of emotional distress [35], and among those with AMD, emotional distress influences quality of life and the ability to carry out daily activities [35]. Individuals with AMD often experience significant emotional distress, even when the severity of vision loss is considered [36]. Additionally, these are cross-sectional analyses and we are unable to assess the temporality of the association between visual acuity declines and physical activity. Further longitudinal studies, particularly those with a greater number of individuals with late AMD (only 16 participants in the present study had late AMD), are needed to address both the potential influence of duration of vision loss and to clarify the directionality of the association between physical activity and advanced AMD.

A strength of the study is the use of a nationally representative study population, which makes the results generalizable to the U.S. population. Furthermore, objective measures of visual acuity and physical activity were employed unlike previous studies which employed self-reported physical activity. Finally, disease diagnoses were formally made using retinal photographs and a centralized reading center.

In conclusion, the present findings demonstrate that adults with late AMD engage in less MVPA than those without AMD, and this association may be partially explained by decreased visual acuity. Additionally, regardless of the direction of causation, adults with AMD are more likely to engage in unhealthy daily lifestyle movement patterns, underscoring the importance of promoting physical activity and reducing sedentary behavior among adults with AMD. Although speculative, our null findings between AMD and sedentary/light-intensity physical activity behavior suggest that those with AMD do not appear to be restricting their light-intensity physical activity behavior or engaging in more accumulated sedentary behavior. This suggests that a more feasible approach to promoting movement-based behaviors among those with AMD would be to, at least initially, focus on increasing their number of breaks from sedentary behavior (e.g., minimizing prolonged sedentary behavior by, every hour, standing and walking for a few minutes), which, encouragingly, has been shown to beneficially associate with several health outcomes [37]. The inactive lifestyle among this population is particularly concerning as inactivity is associated with increased risk of cognitive decline in adults with AMD [38]. Encouragingly, promotion of physical activity among those with AMD may be feasible given that individuals with AMD do not appear to have worse mobility function than normal sighted individuals of the same age [39]; however, careful reflection and promotion of physical activity among those with late AMD, in particular, is needed as those with late AMD have worse vision and engage in less physical activity than their counterparts. Future longitudinal research further assessing the role of visual acuity decline on the association between AMD and physical activity, as well as examining the effect of the duration of vision loss, is warranted.

Supporting Information

S1 STROBE Checklist.

https://doi.org/10.1371/journal.pone.0125394.s001

(PDF)

Author Contributions

Conceived and designed the experiments: PDL BKS PYR. Performed the experiments: PDL BKS PYR. Analyzed the data: PDL. Wrote the paper: PDL BKS PYR.

References

1. Laatikainen L, Hirvela H (1995) Prevalence and visual consequences of macular changes in a population aged 70 years and older. Acta Ophthalmol Scand 73: 105–110. pmid:7656134
- View Article
- PubMed/NCBI
- Google Scholar
2. Rosenberg T, Klie F (1996) The incidence of registered blindness caused by age-related macular degeneration. Acta Ophthalmol Scand 74: 399–402. pmid:8883559
- View Article
- PubMed/NCBI
- Google Scholar
3. Seddon JM, Chen CA (2004) The epidemiology of age-related macular degeneration. Int Ophthalmol Clin 44: 17–39. pmid:15577562
- View Article
- PubMed/NCBI
- Google Scholar
4. Bandello F, Lafuma A, Berdeaux G (2007) Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity. Invest Ophthalmol Vis Sci 48: 96–103. pmid:17197522
- View Article
- PubMed/NCBI
- Google Scholar
5. Cackett P, Cheung N, Wong TY (2008) Age-related macular degeneration and mortality from cardiovascular disease or stroke. Br J Ophthalmol 92: 1564. pmid:18952662
- View Article
- PubMed/NCBI
- Google Scholar
6. Aquilante K, Yager D, Morris RA, Khmelnitsky F (2001) Low-vision patients with age-related maculopathy read RSVP faster when word duration varies according to word length. Optom Vis Sci 78: 290–296. pmid:11384006
- View Article
- PubMed/NCBI
- Google Scholar
7. Bullimore MA, Bailey IL, Wacker RT (1991) Face recognition in age-related maculopathy. Invest Ophthalmol Vis Sci 32: 2020–2029. pmid:2055696
- View Article
- PubMed/NCBI
- Google Scholar
8. West SK, Munoz B, Rubin GS, Schein OD, Bandeen-Roche K, Zeger S, et al. (1997) Function and visual impairment in a population-based study of older adults. The SEE project. Salisbury Eye Evaluation. Invest Ophthalmol Vis Sci 38: 72–82. pmid:9008632
- View Article
- PubMed/NCBI
- Google Scholar
9. Hochberg C, Maul E, Chan ES, Van Landingham S, Ferrucci L, Friedman DS, et al. (2012) Association of vision loss in glaucoma and age-related macular degeneration with IADL disability. Invest Ophthalmol Vis Sci 53:3201–3206. pmid:22491415
- View Article
- PubMed/NCBI
- Google Scholar
10. Willis JR, Jefferys JL, Vitale S, Ramulu PY (2012) Visual impairment, uncorrected refractive error, and accelerometer-defined physical activity in the United States. Arch Ophthalmol 130: 329–335. pmid:22411662
- View Article
- PubMed/NCBI
- Google Scholar
11. Warburton DE, Charlesworth S, Ivey A, Nettlefold L, Bredin SS (2010) A systematic review of the evidence for Canada's Physical Activity Guidelines for Adults. Int J Behav Nutr Phys Act 7: 39. pmid:20459783
- View Article
- PubMed/NCBI
- Google Scholar
12. Rani PK, Raman R, Gella L, Kulothungan V, Sharma T (2012) Prevalence of Visual Impairment and Associated Risk Factors in Subjects with Type II Diabetes Mellitus: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS, Report 16). Middle East Afr J Ophthalmol 19: 129–134. pmid:22346128
- View Article
- PubMed/NCBI
- Google Scholar
13. Ko F, Vitale S, Chou CF, Cotch MF, Saaddine J, Friedman DS (2012) Prevalence of nonrefractive visual impairment in US adults and associated risk factors, 1999–2002 and 2005–2008. JAMA 308: 2361–2368. pmid:23232894
- View Article
- PubMed/NCBI
- Google Scholar
14. Risk factors for neovascular age-related macular degeneration (1992) The Eye Disease CaseControl Study Group. Arch Ophthalmol 110: 1701–1708. pmid:1281403
- View Article
- PubMed/NCBI
- Google Scholar
15. Knudtson MD, Klein R, Klein BE (2006) Physical activity and the 15-year cumulative incidence of age related macular degeneration: the Beaver Dam Eye Study. Br J Ophthalmol 90: 1461–1463. pmid:17077116
- View Article
- PubMed/NCBI
- Google Scholar
16. Mares JA, Voland RP, Sondel SA, Millen AE, Larowe T, Moeller SM, et al. (2011) Healthy lifestyles related to subsequent prevalence of age-related macular degeneration. Arch Ophthalmol 129: 470–480. pmid:21149749
- View Article
- PubMed/NCBI
- Google Scholar
17. Williams PT (2009) Prospective study of incident age-related macular degeneration in relation to vigorous physical activity during a 7-year follow-up. Invest Ophthalmol Vis Sci 50: 101–106. pmid:18566466
- View Article
- PubMed/NCBI
- Google Scholar
18. Klein R, Cruickshanks KJ, Nash SD, Krantz EM, Nieto FJ, et al. (2010) The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol 128: 750–758. pmid:20547953
- View Article
- PubMed/NCBI
- Google Scholar
19. Munch IC, Linneberg A, Larsen M (2013) Precursors of age-related macular degeneration: associations with physical activity, obesity, and serum lipids in the inter99 eye study. Invest Ophthalmol Vis Sci 54: 3932–3940. pmid:23652489
- View Article
- PubMed/NCBI
- Google Scholar
20. Shephard RJ (2003) Limits to the measurement of habitual physical activity by questionnaires. Br J Sports Med 37: 197–206; discussion 206. pmid:12782543
- View Article
- PubMed/NCBI
- Google Scholar
21. Westerterp KR (2009) Assessment of physical activity: a critical appraisal. Eur J Appl Physiol 105: 823–828. pmid:19205725
- View Article
- PubMed/NCBI
- Google Scholar
22. van Poppel MN, Chinapaw MJ, Mokkink LB, van Mechelen W, Terwee CB (2010) Physical activity questionnaires for adults: a systematic review of measurement properties. Sports Med 40: 565–600. pmid:20545381
- View Article
- PubMed/NCBI
- Google Scholar
23. Matthews CE, Chen KY, Freedson PS, Buchowski MS, Beech BM, Pate RR, et al. (2008) Amount of time spent in sedentary behaviors in the United States, 2003–2004. Am J Epidemiol 167: 875–881. pmid:18303006
- View Article
- PubMed/NCBI
- Google Scholar
24. Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M (2008) Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc 40: 181–188. pmid:18091006
- View Article
- PubMed/NCBI
- Google Scholar
25. Loprinzi PD, Ramulu PY (2013) Objectively Measured Physical Activity and Inflammatory Markers Among US Adults With Diabetes: Implications for Attenuating Disease Progression. Mayo Clin Proc 88: 942–951. pmid:24001486
- View Article
- PubMed/NCBI
- Google Scholar
26. Loprinzi PD, Lee H, Cardinal BJ (2013) Dose Response Association between Physical Activity and Biological, Demographic, and Perceptions of Health Variables. Obes Facts 6: 380–392. pmid:23970147
- View Article
- PubMed/NCBI
- Google Scholar
27. Richman J, Lorenzana LL, Lankaranian D, Dugar J, Mayer J, Wizov SS, et al. (2010) Importance of visual acuity and contrast sensitivity in patients with glaucoma. Arch Ophthalmol 128: 1576–1582. pmid:21149782
- View Article
- PubMed/NCBI
- Google Scholar
28. Scilley K, Jackson GR, Cideciyan AV, Maguire MG, Jacobson SG, Owsley C (2002) Early age related maculopathy and self-reported visual difficulty in daily life. Ophthalmology 109: 1235–1242. pmid:12093644
- View Article
- PubMed/NCBI
- Google Scholar
29. Loprinzi PD, Pariser G, Ramulu PY (2013) Accelerometer-Assessed Sedentary and Physical Activity Behavior and its Association With Vision Among U.S. Adults With Diabetes. J Phys Act Health.
30. Willis JR, Vitale SE, Agrawal Y, Ramulu PY (2013) Visual impairment, uncorrected refractive error, and objectively measured balance in the United States. JAMA Ophthalmol 131: 1049–1056. pmid:23744090
- View Article
- PubMed/NCBI
- Google Scholar
31. Chomistek AK, Manson JE, Stefanick ML, Lu B, Sands-Lincoln M, Going SB, et al. (2013) Relationship of sedentary behavior and physical activity to incident cardiovascular disease: results from theWomen's Health Initiative. J Am Coll Cardiol 61: 2346–2354. pmid:23583242
- View Article
- PubMed/NCBI
- Google Scholar
32. Ford ES, Caspersen CJ (2012) Sedentary behaviour and cardiovascular disease: a review of prospective studies. Int J Epidemiol 41: 1338–1353. pmid:22634869
- View Article
- PubMed/NCBI
- Google Scholar
33. Subhi Y, Singh A, Falk MK, Sorensen TL (2014) In patients with neovascular age-related macular degeneration, physical activity may influence C-reactive protein levels. Clin Ophthalmol 4: 15–21. pmid:24363550
- View Article
- PubMed/NCBI
- Google Scholar
34. McPhillips JB, Pellettera KM, Barrett-Connor E, Wingard DL, Criqui MH (1989) Exercise patterns in a population of older adults. Am J Prev Med 5: 65–72. pmid:2730794
- View Article
- PubMed/NCBI
- Google Scholar
35. Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI (1998) The psychosocial impact of macular degeneration. Arch Ophthalmol 116: 514–520. pmid:9565052
- View Article
- PubMed/NCBI
- Google Scholar
36. Casten RJ, Rovner BW, Tasman W (2004) Age-related macular degeneration and depression: a review of recent research. Curr Opin Ophthalmol 15: 181–183. pmid:15118503
- View Article
- PubMed/NCBI
- Google Scholar
37. Healy GN, Dunstan DW, Salmon J, Cerin E, Shaw JE, Zimmet PZ, et al. (2008) Breaks in sedentary time: beneficial associations with metabolic risk. Diabetes Care 31: 661–666. pmid:18252901
- View Article
- PubMed/NCBI
- Google Scholar
38. Rovner BW, Casten RJ, Leiby BE, Tasman WS (2009) Activity loss is associated with cognitive decline in age-related macular degeneration. Alzheimers Dement 5: 12–17. pmid:19118805
- View Article
- PubMed/NCBI
- Google Scholar
39. Hassan SE, Lovie-Kitchin JE, Woods RL (2002) Vision and mobility performance of subjects with age related macular degeneration. Optom Vis Sci 79: 697–707. pmid:12462538
- View Article
- PubMed/NCBI
- Google Scholar

[ref1] 1. Laatikainen L, Hirvela H (1995) Prevalence and visual consequences of macular changes in a population aged 70 years and older. Acta Ophthalmol Scand 73: 105–110. pmid:7656134
View Article
PubMed/NCBI
Google Scholar

[2] View Article

[3] PubMed/NCBI

[4] Google Scholar

[ref2] 2. Rosenberg T, Klie F (1996) The incidence of registered blindness caused by age-related macular degeneration. Acta Ophthalmol Scand 74: 399–402. pmid:8883559
View Article
PubMed/NCBI
Google Scholar

[6] View Article

[7] PubMed/NCBI

[8] Google Scholar

[ref3] 3. Seddon JM, Chen CA (2004) The epidemiology of age-related macular degeneration. Int Ophthalmol Clin 44: 17–39. pmid:15577562
View Article
PubMed/NCBI
Google Scholar

[10] View Article

[11] PubMed/NCBI

[12] Google Scholar

[ref4] 4. Bandello F, Lafuma A, Berdeaux G (2007) Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity. Invest Ophthalmol Vis Sci 48: 96–103. pmid:17197522
View Article
PubMed/NCBI
Google Scholar

[14] View Article

[15] PubMed/NCBI

[16] Google Scholar

[ref5] 5. Cackett P, Cheung N, Wong TY (2008) Age-related macular degeneration and mortality from cardiovascular disease or stroke. Br J Ophthalmol 92: 1564. pmid:18952662
View Article
PubMed/NCBI
Google Scholar

[18] View Article

[19] PubMed/NCBI

[20] Google Scholar

[ref6] 6. Aquilante K, Yager D, Morris RA, Khmelnitsky F (2001) Low-vision patients with age-related maculopathy read RSVP faster when word duration varies according to word length. Optom Vis Sci 78: 290–296. pmid:11384006
View Article
PubMed/NCBI
Google Scholar

[22] View Article

[23] PubMed/NCBI

[24] Google Scholar

[ref7] 7. Bullimore MA, Bailey IL, Wacker RT (1991) Face recognition in age-related maculopathy. Invest Ophthalmol Vis Sci 32: 2020–2029. pmid:2055696
View Article
PubMed/NCBI
Google Scholar

[26] View Article

[27] PubMed/NCBI

[28] Google Scholar

[ref8] 8. West SK, Munoz B, Rubin GS, Schein OD, Bandeen-Roche K, Zeger S, et al. (1997) Function and visual impairment in a population-based study of older adults. The SEE project. Salisbury Eye Evaluation. Invest Ophthalmol Vis Sci 38: 72–82. pmid:9008632
View Article
PubMed/NCBI
Google Scholar

[30] View Article

[31] PubMed/NCBI

[32] Google Scholar

[ref9] 9. Hochberg C, Maul E, Chan ES, Van Landingham S, Ferrucci L, Friedman DS, et al. (2012) Association of vision loss in glaucoma and age-related macular degeneration with IADL disability. Invest Ophthalmol Vis Sci 53:3201–3206. pmid:22491415
View Article
PubMed/NCBI
Google Scholar

[34] View Article

[35] PubMed/NCBI

[36] Google Scholar

[ref10] 10. Willis JR, Jefferys JL, Vitale S, Ramulu PY (2012) Visual impairment, uncorrected refractive error, and accelerometer-defined physical activity in the United States. Arch Ophthalmol 130: 329–335. pmid:22411662
View Article
PubMed/NCBI
Google Scholar

[38] View Article

[39] PubMed/NCBI

[40] Google Scholar

[ref11] 11. Warburton DE, Charlesworth S, Ivey A, Nettlefold L, Bredin SS (2010) A systematic review of the evidence for Canada's Physical Activity Guidelines for Adults. Int J Behav Nutr Phys Act 7: 39. pmid:20459783
View Article
PubMed/NCBI
Google Scholar

[42] View Article

[43] PubMed/NCBI

[44] Google Scholar

[ref12] 12. Rani PK, Raman R, Gella L, Kulothungan V, Sharma T (2012) Prevalence of Visual Impairment and Associated Risk Factors in Subjects with Type II Diabetes Mellitus: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS, Report 16). Middle East Afr J Ophthalmol 19: 129–134. pmid:22346128
View Article
PubMed/NCBI
Google Scholar

[46] View Article

[47] PubMed/NCBI

[48] Google Scholar

[ref13] 13. Ko F, Vitale S, Chou CF, Cotch MF, Saaddine J, Friedman DS (2012) Prevalence of nonrefractive visual impairment in US adults and associated risk factors, 1999–2002 and 2005–2008. JAMA 308: 2361–2368. pmid:23232894
View Article
PubMed/NCBI
Google Scholar

[50] View Article

[51] PubMed/NCBI

[52] Google Scholar

[ref14] 14. Risk factors for neovascular age-related macular degeneration (1992) The Eye Disease CaseControl Study Group. Arch Ophthalmol 110: 1701–1708. pmid:1281403
View Article
PubMed/NCBI
Google Scholar

[54] View Article

[55] PubMed/NCBI

[56] Google Scholar

[ref15] 15. Knudtson MD, Klein R, Klein BE (2006) Physical activity and the 15-year cumulative incidence of age related macular degeneration: the Beaver Dam Eye Study. Br J Ophthalmol 90: 1461–1463. pmid:17077116
View Article
PubMed/NCBI
Google Scholar

[58] View Article

[59] PubMed/NCBI

[60] Google Scholar

[ref16] 16. Mares JA, Voland RP, Sondel SA, Millen AE, Larowe T, Moeller SM, et al. (2011) Healthy lifestyles related to subsequent prevalence of age-related macular degeneration. Arch Ophthalmol 129: 470–480. pmid:21149749
View Article
PubMed/NCBI
Google Scholar

[62] View Article

[63] PubMed/NCBI

[64] Google Scholar

[ref17] 17. Williams PT (2009) Prospective study of incident age-related macular degeneration in relation to vigorous physical activity during a 7-year follow-up. Invest Ophthalmol Vis Sci 50: 101–106. pmid:18566466
View Article
PubMed/NCBI
Google Scholar

[66] View Article

[67] PubMed/NCBI

[68] Google Scholar

[ref18] 18. Klein R, Cruickshanks KJ, Nash SD, Krantz EM, Nieto FJ, et al. (2010) The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol 128: 750–758. pmid:20547953
View Article
PubMed/NCBI
Google Scholar

[70] View Article

[71] PubMed/NCBI

[72] Google Scholar

[ref19] 19. Munch IC, Linneberg A, Larsen M (2013) Precursors of age-related macular degeneration: associations with physical activity, obesity, and serum lipids in the inter99 eye study. Invest Ophthalmol Vis Sci 54: 3932–3940. pmid:23652489
View Article
PubMed/NCBI
Google Scholar

[74] View Article

[75] PubMed/NCBI

[76] Google Scholar

[ref20] 20. Shephard RJ (2003) Limits to the measurement of habitual physical activity by questionnaires. Br J Sports Med 37: 197–206; discussion 206. pmid:12782543
View Article
PubMed/NCBI
Google Scholar

[78] View Article

[79] PubMed/NCBI

[80] Google Scholar

[ref21] 21. Westerterp KR (2009) Assessment of physical activity: a critical appraisal. Eur J Appl Physiol 105: 823–828. pmid:19205725
View Article
PubMed/NCBI
Google Scholar

[82] View Article

[83] PubMed/NCBI

[84] Google Scholar

[ref22] 22. van Poppel MN, Chinapaw MJ, Mokkink LB, van Mechelen W, Terwee CB (2010) Physical activity questionnaires for adults: a systematic review of measurement properties. Sports Med 40: 565–600. pmid:20545381
View Article
PubMed/NCBI
Google Scholar

[86] View Article

[87] PubMed/NCBI

[88] Google Scholar

[ref23] 23. Matthews CE, Chen KY, Freedson PS, Buchowski MS, Beech BM, Pate RR, et al. (2008) Amount of time spent in sedentary behaviors in the United States, 2003–2004. Am J Epidemiol 167: 875–881. pmid:18303006
View Article
PubMed/NCBI
Google Scholar

[90] View Article

[91] PubMed/NCBI

[92] Google Scholar

[ref24] 24. Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M (2008) Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc 40: 181–188. pmid:18091006
View Article
PubMed/NCBI
Google Scholar

[94] View Article

[95] PubMed/NCBI

[96] Google Scholar

[ref25] 25. Loprinzi PD, Ramulu PY (2013) Objectively Measured Physical Activity and Inflammatory Markers Among US Adults With Diabetes: Implications for Attenuating Disease Progression. Mayo Clin Proc 88: 942–951. pmid:24001486
View Article
PubMed/NCBI
Google Scholar

[98] View Article

[99] PubMed/NCBI

[100] Google Scholar

[ref26] 26. Loprinzi PD, Lee H, Cardinal BJ (2013) Dose Response Association between Physical Activity and Biological, Demographic, and Perceptions of Health Variables. Obes Facts 6: 380–392. pmid:23970147
View Article
PubMed/NCBI
Google Scholar

[102] View Article

[103] PubMed/NCBI

[104] Google Scholar

[ref27] 27. Richman J, Lorenzana LL, Lankaranian D, Dugar J, Mayer J, Wizov SS, et al. (2010) Importance of visual acuity and contrast sensitivity in patients with glaucoma. Arch Ophthalmol 128: 1576–1582. pmid:21149782
View Article
PubMed/NCBI
Google Scholar

[106] View Article

[107] PubMed/NCBI

[108] Google Scholar

[ref28] 28. Scilley K, Jackson GR, Cideciyan AV, Maguire MG, Jacobson SG, Owsley C (2002) Early age related maculopathy and self-reported visual difficulty in daily life. Ophthalmology 109: 1235–1242. pmid:12093644
View Article
PubMed/NCBI
Google Scholar

[110] View Article

[111] PubMed/NCBI

[112] Google Scholar

[ref29] 29. Loprinzi PD, Pariser G, Ramulu PY (2013) Accelerometer-Assessed Sedentary and Physical Activity Behavior and its Association With Vision Among U.S. Adults With Diabetes. J Phys Act Health.

[ref30] 30. Willis JR, Vitale SE, Agrawal Y, Ramulu PY (2013) Visual impairment, uncorrected refractive error, and objectively measured balance in the United States. JAMA Ophthalmol 131: 1049–1056. pmid:23744090
View Article
PubMed/NCBI
Google Scholar

[115] View Article

[116] PubMed/NCBI

[117] Google Scholar

[ref31] 31. Chomistek AK, Manson JE, Stefanick ML, Lu B, Sands-Lincoln M, Going SB, et al. (2013) Relationship of sedentary behavior and physical activity to incident cardiovascular disease: results from theWomen's Health Initiative. J Am Coll Cardiol 61: 2346–2354. pmid:23583242
View Article
PubMed/NCBI
Google Scholar

[119] View Article

[120] PubMed/NCBI

[121] Google Scholar

[ref32] 32. Ford ES, Caspersen CJ (2012) Sedentary behaviour and cardiovascular disease: a review of prospective studies. Int J Epidemiol 41: 1338–1353. pmid:22634869
View Article
PubMed/NCBI
Google Scholar

[123] View Article

[124] PubMed/NCBI

[125] Google Scholar

[ref33] 33. Subhi Y, Singh A, Falk MK, Sorensen TL (2014) In patients with neovascular age-related macular degeneration, physical activity may influence C-reactive protein levels. Clin Ophthalmol 4: 15–21. pmid:24363550
View Article
PubMed/NCBI
Google Scholar

[127] View Article

[128] PubMed/NCBI

[129] Google Scholar

[ref34] 34. McPhillips JB, Pellettera KM, Barrett-Connor E, Wingard DL, Criqui MH (1989) Exercise patterns in a population of older adults. Am J Prev Med 5: 65–72. pmid:2730794
View Article
PubMed/NCBI
Google Scholar

[131] View Article

[132] PubMed/NCBI

[133] Google Scholar

[ref35] 35. Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI (1998) The psychosocial impact of macular degeneration. Arch Ophthalmol 116: 514–520. pmid:9565052
View Article
PubMed/NCBI
Google Scholar

[135] View Article

[136] PubMed/NCBI

[137] Google Scholar

[ref36] 36. Casten RJ, Rovner BW, Tasman W (2004) Age-related macular degeneration and depression: a review of recent research. Curr Opin Ophthalmol 15: 181–183. pmid:15118503
View Article
PubMed/NCBI
Google Scholar

[139] View Article

[140] PubMed/NCBI

[141] Google Scholar

[ref37] 37. Healy GN, Dunstan DW, Salmon J, Cerin E, Shaw JE, Zimmet PZ, et al. (2008) Breaks in sedentary time: beneficial associations with metabolic risk. Diabetes Care 31: 661–666. pmid:18252901
View Article
PubMed/NCBI
Google Scholar

[143] View Article

[144] PubMed/NCBI

[145] Google Scholar

[ref38] 38. Rovner BW, Casten RJ, Leiby BE, Tasman WS (2009) Activity loss is associated with cognitive decline in age-related macular degeneration. Alzheimers Dement 5: 12–17. pmid:19118805
View Article
PubMed/NCBI
Google Scholar

[147] View Article

[148] PubMed/NCBI

[149] Google Scholar

[ref39] 39. Hassan SE, Lovie-Kitchin JE, Woods RL (2002) Vision and mobility performance of subjects with age related macular degeneration. Optom Vis Sci 79: 697–707. pmid:12462538
View Article
PubMed/NCBI
Google Scholar

[151] View Article

[152] PubMed/NCBI

[153] Google Scholar

Figures

Abstract

Background

Methods

Results

Conclusions

Introduction

Methods

Design and Participants

Assessment of Age-Related Macular Degeneration

Assessment of Physical Activity

Daily Movement Patterns

Measurement of Covariates

Data Analysis

Results

Discussion

Supporting Information

S1 STROBE Checklist.

Author Contributions

References